These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33325396)

  • 41. Association Between APOE Alleles and Change of Neuropsychological Tests in the Long Life Family Study.
    Du M; Andersen SL; Schupf N; Feitosa MF; Barker MS; Perls TT; Sebastiani P
    J Alzheimers Dis; 2021; 79(1):117-125. PubMed ID: 33216038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterizing the Effects of Sex, APOE ɛ4, and Literacy on Mid-life Cognitive Trajectories: Application of Information-Theoretic Model Averaging and Multi-model Inference Techniques to the Wisconsin Registry for Alzheimer's Prevention Study.
    Koscik RL; Norton DL; Allison SL; Jonaitis EM; Clark LR; Mueller KD; Hermann BP; Engelman CD; Gleason CE; Sager MA; Chappell RJ; Johnson SC
    J Int Neuropsychol Soc; 2019 Feb; 25(2):119-133. PubMed ID: 30522545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex Differences in Cognitive Changes in De Novo Parkinson's Disease.
    Bayram E; Banks SJ; Shan G; Kaplan N; Caldwell JZK
    J Int Neuropsychol Soc; 2020 Feb; 26(2):241-249. PubMed ID: 31822306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia.
    Tropea TF; Mak J; Guo MH; Xie SX; Suh E; Rick J; Siderowf A; Weintraub D; Grossman M; Irwin D; Wolk DA; Trojanowski JQ; Van Deerlin V; Chen-Plotkin AS
    Ann Neurol; 2019 Jun; 85(6):801-811. PubMed ID: 30973966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detecting At-Risk Alzheimer's Disease Cases.
    Fladby T; Pålhaugen L; Selnes P; Waterloo K; Bråthen G; Hessen E; Almdahl IS; Arntzen KA; Auning E; Eliassen CF; Espenes R; Grambaite R; Grøntvedt GR; Johansen KK; Johnsen SH; Kalheim LF; Kirsebom BE; Müller KI; Nakling AE; Rongve A; Sando SB; Siafarikas N; Stav AL; Tecelao S; Timon S; Bekkelund SI; Aarsland D
    J Alzheimers Dis; 2017; 60(1):97-105. PubMed ID: 28826181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
    Basta M; Zaganas I; Simos P; Koutentaki E; Dimovasili C; Mathioudakis L; Bourbouli M; Panagiotakis S; Kapetanaki S; Vgontzas A
    J Alzheimers Dis; 2021; 79(2):763-771. PubMed ID: 33361595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson's Disease.
    Zhang L; Gu LY; Dai SB; Zheng R; Jin CY; Fang Y; Yang WY; Tian J; Yin XZ; Zhao GH; Pu JL; Zhang BR; Yan YP; Chen Y
    Eur Neurol; 2022; 85(1):24-30. PubMed ID: 34689144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.
    Nazem S; Siderowf AD; Duda JE; Have TT; Colcher A; Horn SS; Moberg PJ; Wilkinson JR; Hurtig HI; Stern MB; Weintraub D
    J Am Geriatr Soc; 2009 Feb; 57(2):304-8. PubMed ID: 19170786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apolipoprotein E and sex modulate fatty acid metabolism in a prospective observational study of cognitive decline.
    González-Domínguez R; Castellano-Escuder P; Lefèvre-Arbogast S; Low DY; Du Preez A; Ruigrok SR; Lee H; Helmer C; Pallàs M; Urpi-Sarda M; Sánchez-Pla A; Korosi A; Lucassen PJ; Aigner L; Manach C; Thuret S; Samieri C; Andres-Lacueva C
    Alzheimers Res Ther; 2022 Jan; 14(1):1. PubMed ID: 34980257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Active Lifestyle Is Associated with Better Cognitive Function Over Time in APOE ɛ4 Non-Carriers.
    Fernández-Matarrubia M; Goni L; Rognoni T; Razquin C; Fernández-Lázaro CI; Bes-Rastrollo M; Martínez-González MÁ; Toledo E
    J Alzheimers Dis; 2021; 79(3):1257-1268. PubMed ID: 33427740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. APOE ε4 Modulation of Training Outcomes in Several Cognitive Domains in a Sample of Cognitively Intact Older Adults.
    López-Higes R; Rodríguez-Rojo IC; Prados JM; Montejo P; Del-Río D; Delgado-Losada ML; Montenegro M; López-Sanz D; Barabash A
    J Alzheimers Dis; 2017; 58(4):1201-1215. PubMed ID: 28550244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson's disease.
    Hong JH; Kim YK; Park JS; Lee JE; Oh MS; Chung EJ; Kim JY; Sung YH; Lyoo CH; Lee JH; Kwon DY; Kim HS; Shin HW; Park SA; Park IS; Kim JS; Lee PH; Koh SB; Baik JS; Kim SJ; Ma HI; Kim JW; Kim YJ
    J Clin Neurosci; 2017 Feb; 36():108-113. PubMed ID: 27839916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subjective Cognitive Decline and APOE ɛ4: A Systematic Review.
    Ali JI; Smart CM; Gawryluk JR
    J Alzheimers Dis; 2018; 65(1):303-320. PubMed ID: 30040718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anterior Cingulate Structure and Perfusion is Associated with Cerebrospinal Fluid Tau among Cognitively Normal Older Adult APOEɛ4 Carriers.
    Hays CC; Zlatar ZZ; Meloy MJ; Osuna J; Liu TT; Galasko DR; Wierenga CE
    J Alzheimers Dis; 2020; 73(1):87-101. PubMed ID: 31743999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.
    Gomperts SN; Locascio JJ; Rentz D; Santarlasci A; Marquie M; Johnson KA; Growdon JH
    Neurology; 2013 Jan; 80(1):85-91. PubMed ID: 23243071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physical Activity, APOE Genotype, and Cognitive Decline: Exploring Gene-Environment Interactions in the UK Biobank.
    Folley S; Zhou A; Llewellyn DJ; Hyppönen E
    J Alzheimers Dis; 2019; 71(3):741-750. PubMed ID: 31450492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations.
    Mangone G; Bekadar S; Cormier-Dequaire F; Tahiri K; Welaratne A; Czernecki V; Pineau F; Karachi C; Castrioto A; Durif F; Tranchant C; Devos D; Thobois S; Meissner WG; Navarro MS; Cornu P; Lesage S; Brice A; Welter ML; Corvol JC;
    Parkinsonism Relat Disord; 2020 Jul; 76():56-62. PubMed ID: 32866938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.
    Mata IF; Leverenz JB; Weintraub D; Trojanowski JQ; Hurtig HI; Van Deerlin VM; Ritz B; Rausch R; Rhodes SL; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson AL; Espay AJ; Revilla FJ; Devoto J; Hu SC; Cholerton BA; Wan JY; Montine TJ; Edwards KL; Zabetian CP
    JAMA Neurol; 2014 Nov; 71(11):1405-12. PubMed ID: 25178429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults.
    Hollands S; Lim YY; Laws SM; Villemagne VL; Pietrzak RH; Harrington K; Porter T; Snyder P; Ames D; Fowler C; Rainey-Smith SR; Martins RN; Salvado O; Robertson J; Rowe CC; Masters CL; Maruff P;
    J Alzheimers Dis; 2017; 57(2):411-422. PubMed ID: 28234254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Computerized testing in Parkinson's disease: Performance deficits in relation to standard clinical measures.
    Flannery SL; Jowett T; Garvey A; Cutfield NJ; Machado L
    J Clin Exp Neuropsychol; 2018 Dec; 40(10):1062-1073. PubMed ID: 29978753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.